HASHKEY HLDGS(03887): Partial exercise of the excess rights issue, stabilization actions and the end of the price stabilization period.
HASHKEY Holdings (03887) announced that on January 9, 2026 (Friday), the excess rights issue as stated in the prospectus was partially exercised by the overall coordinator (on behalf of international underwriters) at a price of HK$6.68 per share (excluding 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% HKEX trading fee, and 0.00565% HKEX transaction levy), involving a total of 892,400 shares, representing approximately 0.37% of the total number of shares available for subscription under the global offering before the exercise of any excess rights, to top up the excess allocation in the international offering.
HASHKEY Holdings (03887) announced that on January 9, 2026 (Friday), the excess rights issue as stated in the prospectus was partially exercised by the global coordinator (on behalf of the international underwriters) at HK$6.68 per share (excluding 1.0% brokerage commission, 0.0027% SFC trading fee, 0.00015% HKEX trading fee, and 0.00565% HKEX trading fee), involving a total of 892,400 shares, representing approximately 0.37% of the total number of shares available for subscription under the global offering before the exercise of any excess rights. This is done to supplement the excess allocation in the international offering.
Furthermore, the stabilization period for the global offering will end on January 11, 2026 (Sunday) (i.e. the 30th day after the deadline for submitting applications for public offering in Hong Kong).
Related Articles

CES Insight from France and Brazil: Siasun Robot & Automation reaches the critical point of commercialization with the AI wave. NVIDIA Corporation (NVDA.US) emerges as a winner.

New Stock News | Montage Technology (688008.SH) Hong Kong IPO Prospectus Invalid

HK Stock Market Move | MEDBOT-B(02252) rose more than 7% in early trading. Siasun Robot & Automation recently completed the world's first large model autonomous surgery animal experiment.
CES Insight from France and Brazil: Siasun Robot & Automation reaches the critical point of commercialization with the AI wave. NVIDIA Corporation (NVDA.US) emerges as a winner.

New Stock News | Montage Technology (688008.SH) Hong Kong IPO Prospectus Invalid

HK Stock Market Move | MEDBOT-B(02252) rose more than 7% in early trading. Siasun Robot & Automation recently completed the world's first large model autonomous surgery animal experiment.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


